Luana Raposo de Melo Moraes Aps

• Abstract

  he emergence of betacoronavirus SARS-CoV-2 at the end of 2019 in China lasts for almost a year and has already resulted in more than 30 million infections and 1 million deaths worldwide. Vaccines are essential and urgently needed to control the pandemic and the strategies under development are mostly aimed at inducing antibodies against the viral protein spike, responsible for binding to …

  Development of a T-cell-inducing vaccine against SARS-CoV-2 infection, AP.PIPE

• Abstract

  Human papillomavirus (HPV) infection is considered the most common sexually transmitted disease and eight out of ten people have ever come into contact with it at some point in their lives. Most HPV infections are asymptomatic and are controlled by the immune system without intervention. However, persistent infections caused by this virus can lead to the onset of both uterine cervix lesio…

  Translational development and preclinical validation of an immunotherapy against tumors induced by human papillomavirus (HPV), AP.PIPE

• Development of a T-cell-inducing vaccine against SARS-CoV-2 infection, BP.PIPE
• Translational development and preclinical validation of an immunotherapy against tumors induced by Human Papillomavirus (HPV), BP.PIPE

• Abstract

  Human papilloma virus (HPV) is responsible for 99,7% of cervical cancer cases and approximately 5% of all cancers worldwide, and HPV-16 is the main etiological agent of this disease. The development of therapies to control HPV-induced tumors searches the establishment of a new treatment based on immunotherapy that is advantageous compared with traditional invasive and aggressive procedure…

  New therapeutic frontiers against tumors caused by human papilloma virus (HPV): experimental evaluation of the chemotherapy in association to vaccine strategies, BP.DR

(Only some records are available in English at this moment)